Stockscreener 앱 받기
175.26
0.26%
0.45
시간 외 거래:
175.26
전일 마감가:
$174.81
열려 있는:
$174.5
하루 거래량:
3.55M
Relative Volume:
0.61
시가총액:
$309.71B
수익:
$55.53B
순이익/손실:
$5.12B
주가수익비율:
60.85
EPS:
2.88
순현금흐름:
$15.62B
1주 성능:
+3.58%
1개월 성능:
-1.54%
6개월 성능:
-3.67%
1년 성능:
+6.92%
1일 변동 폭
$174.30
$176.92
1주일 범위
$168.48
$177.45
52주 변동 폭
$153.58
$207.32
애브비 Stock (ABBV) Company Profile
명칭
Abbvie Inc
전화
(847) 932-7900
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
ABBV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
175.26 | 309.71B | 55.53B | 5.12B | 15.62B | 2.88 |
|
LLY
Lilly Eli Co
|
804.08 | 764.20B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
84.03 | 373.06B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
151.15 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
MRK
Merck Co Inc
|
98.28 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
애브비 Stock (ABBV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-05 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-04 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-01-29 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-12-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-10-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-09-29 | 개시 | Raymond James | Outperform |
| 2023-07-25 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-05 | 다운그레이드 | Argus | Buy → Hold |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2023-02-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | 업그레이드 | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-11-08 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Underperform |
| 2022-05-06 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2022-02-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-03 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-03 | 재확인 | Barclays | Equal Weight |
| 2022-02-03 | 재확인 | BofA Securities | Neutral |
| 2022-02-03 | 재확인 | Goldman | Neutral |
| 2022-01-13 | 개시 | Redburn | Buy |
| 2022-01-12 | 재확인 | BMO Capital Markets | Outperform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-11-23 | 업그레이드 | Societe Generale | Hold → Buy |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-23 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 업그레이드 | Argus | Hold → Buy |
| 2020-05-18 | 재개 | BofA/Merrill | Neutral |
| 2020-05-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 재개 | Morgan Stanley | Overweight |
| 2020-04-20 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 재확인 | Cowen | Outperform |
| 2019-09-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-20 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-04-29 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
모두보기
애브비 주식(ABBV)의 최신 뉴스
AbbVie (NYSE:ABBV) Shares Up 2.5%Time to Buy? - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 1%Here's Why - MarketBeat
Foster Victor Wealth Advisors LLC Grows Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Is AbbVie Inc. (ABBV) the Best Stock to Buy in 2025 for Beginners? - Yahoo Finance
Asset Dedication LLC Sells 4,388 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Sumitomo Life Insurance Co. Sells 9,798 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kennedy Investment Group Boosts Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Orca Wealth Management LLC Takes $1.86 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Acquired by BSW Wealth Partners - MarketBeat
YHB Investment Advisors Inc. Buys 3,352 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Perigon Wealth Management LLC Buys 17,432 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans - PR Newswire
AbbVie (ABBV) to Release Quarterly Earnings on Friday - MarketBeat
Pancreatic Cancer Pipeline 2024: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Incyte, AbbVie, Ability Pharma, AB Science, AstraZeneca, Eleison Pharma - Barchart
AbbVie Inc. stock outperforms competitors despite losses on the day - MarketWatch
A Glimpse Into The Expert Outlook On AbbVie Through 15 Analysts - Benzinga
AbbVie (NYSE:ABBV) Trading Down 0.1% Following Analyst Downgrade - MarketBeat
AbbVie (NYSE:ABBV) Price Target Lowered to $205.00 at Citigroup - MarketBeat
AbbVie Q4 Earnings Loom: Buy or Sell ABBV Stock Ahead of Results? - Yahoo Finance
BankPlus Wealth Management LLC Makes New Investment in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Citigroup Adjusts Price Target on AbbVie to $205 From $215, Maintains Buy Rating -January 28, 2025 at 06:48 am EST - Marketscreener.com
Court Place Advisors LLC Cuts Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Nilsine Partners LLC Has $1.71 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One. - The Motley Fool
AbbVie Inc. (NYSE:ABBV) Shares Sold by Pacer Advisors Inc. - MarketBeat
Foundations Investment Advisors LLC Sells 44,138 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Baldwin Wealth Partners LLC MA Lowers Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Mount Yale Investment Advisors LLC Acquires 1,514 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc - Yahoo Finance
Summit Financial Strategies Inc. Purchases 4,441 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Webster Bank N. A. Cuts Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kingswood Wealth Advisors LLC Has $2.19 Million Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Stock Volatile On $200M Deal To Buy Nimble Therapeutics: Retail Still Bearish - MSN
AbbVie's SWOT analysis: biopharma giant navigates post-Humira landscape - MSN
Abbvie seeks molecular glue degraders from Neomorph - BioCentury
AbbVie Defies Market Trends! Investors See Rewarding Gains. - Jomfruland.net
Why AbbVie Stock Popped While the Market Flopped on Monday - MSN
AbbVie (ABBV) Stock Rises Following Analyst Price Target Increas - GuruFocus.com
AbbVie Builds Momentum With Immunology Growth, Goldman Remains PositiveAbbVie (NYSE:ABBV) - Benzinga
Piper Sandler raises AbbVie stock target to $227, keeps Overweight rating - Investing.com India
Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't? - Yahoo Finance
AbbVie A Top Socially Responsible Dividend Stock With 3.9% Yield - Forbes
Cathy Pareto & Associates Inc. Buys Shares of 1,799 AbbVie Inc. (NYSE:ABBV) - MarketBeat
KBC Group NV Boosts Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie a Top 25 Dividend Giant With 3.85% Yield (ABBV) - Nasdaq
Blue Trust Inc. Acquires 8,059 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Has $15.12 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Plaque Psoriasis Market Growth Drivers, Future Innovations and Forecasts 2032 | AbbVie Inc, Novartis - EIN News
Crescent Grove Advisors LLC Purchases 2,696 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Jamison Private Wealth Management Inc. Has $10.35 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Novare Capital Management LLC Has $10.34 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
애브비 (ABBV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.51%
1.36%
자본화:
|
볼륨(24시간):